Abiomed, part of Johnson & Johnson MedTech, recently presented positive results from the first completed pivotal trial on Impella ECP, a novel transvalvular axial flow pump with compressible pump ...
NEW YORK, United States, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Axial Flow Impeller Pumps Market By Type (Horizontal And Vertical), By ...
Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly increased the rate of survival at six months among people suffering cardiogenic shock, according to ...
In two interim analyses of this trial, patients with advanced heart failure who were treated with a fully magnetically levitated centrifugal-flow left ventricular assist device were less likely to ...
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed’s (NASDAQ: ABMD) newest heart pump, the Impella 5.5 with SmartAssist, has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback